Fragile Histidine Triad Gene Inactivation in Lung Cancer

American Journal of Respiratory and Critical Care Medicine - United States
doi 10.1164/rccm.200807-1153oc
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Thoracic Society

Related search

Lack of Association of Fragile Histidine Triad (FHIT) Polymorphisms With Lung Cancer in the Korean Population

Journal of Human Genetics
Genetics
2007English

Inactivation ofLLC1 Gene in Nonsmall Cell Lung Cancer

International Journal of Cancer
Cancer ResearchOncology
2007English

Epigenetic Inactivation of the RUNX3 Gene in Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2006English

The Significance of Fragile Histidine Triad Protein as a Molecular Prognostic Marker of Bladder Urothelial Carcinoma

Journal of International Medical Research
BiochemistryMedicineCell Biology
2012English

Fragile Histidine Triad Transcription Abnormalities and Human Papillomavirus E6–E7 mRNA Expression in the Development of Cervical Carcinoma

Cancer
Cancer ResearchOncology
1999English

Structural Characterization of Human Histidine Triad Nucleotide-Binding Protein 2, a Member of the Histidine Triad Superfamily

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2013English

Fragile Histidine Triad Transcription Abnormalities and Human Papillomavirus E6–E7 mRNA Expression in the Development of Cervical Carcinoma

Cancer
Cancer ResearchOncology
1999English

Passenger Mutations Can Accelerate Tumour Suppressor Gene Inactivation in Cancer Evolution

Journal of the Royal Society Interface
BiochemistryBiophysicsBiomaterialsBiotechnologyBioengineeringBiomedical Engineering
2018English

Inactivation of the FHIT Gene Favors Bladder Cancer Development

Clinical Cancer Research
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy